< Back to previous page
Publication
Three Years After CARMENA: What Have We Learned?
Journal Contribution - Journal Editorial
Cytoreductive nephrectomy makes way for more effective systemic treatments in the current mRCC treatment paradigm, as disease volume and the number of IMDC risk factors increase. Careful patient selection for upfront or deferred cytoreductive nephrectomy based on these criteria remains key.
Journal: EUROPEAN UROLOGY
ISSN: 0302-2838
Issue: 4
Volume: 80
Pages: 425 - 427
Publication year:2021
Accessibility:Closed